North China Pharmaceutical Company.Ltd (SHA:600812)
China flag China · Delayed Price · Currency is CNY
5.25
+0.03 (0.57%)
Apr 28, 2026, 3:00 PM CST

SHA:600812 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
9,2429,79810,07010,44910,304
Other Revenue
-71.7650.3251.1980.2
9,2429,87010,12010,50010,385
Revenue Growth (YoY)
-6.36%-2.48%-3.62%1.11%-9.64%
Cost of Revenue
6,3766,7326,9077,0636,691
Gross Profit
2,8653,1383,2133,4373,694
Selling, General & Admin
1,7852,0102,2682,4242,796
Research & Development
341336.15294.2215.17151.93
Other Operating Expenses
73.690.82104.23117.57123.33
Operating Expenses
2,2442,4652,6772,8023,094
Operating Income
621.36672.93536.44634.8600.11
Interest Expense
-361.55-458.7-501.9-599.39-642.69
Interest & Investment Income
86.4471.4274.5284.17126.62
Currency Exchange Gain (Loss)
-17.5711.4923.31-8.32
Other Non Operating Income (Expenses)
-6.9-5.15-11.35-748.96-13.91
EBT Excluding Unusual Items
339.35298.08109.2-606.0761.82
Impairment of Goodwill
--3.34---
Gain (Loss) on Sale of Assets
0.830.310.760.213.4
Asset Writedown
17.23-1.26-0.05--
Legal Settlements
--0.5-0.49-0.78-1.14
Other Unusual Items
-16.5549.1241.5670.84
Pretax Income
357.41309.83158.54-565.07134.91
Income Tax Expense
99.9694.87109.15113.7199.52
Earnings From Continuing Operations
257.45214.9749.39-678.7835.38
Minority Interest in Earnings
-74.4-87.97-44.5-10.45-16.65
Net Income
183.06126.994.89-689.2318.73
Net Income to Common
183.06126.994.89-689.2318.73
Net Income Growth
44.15%2496.79%---80.76%
Shares Outstanding (Basic)
1,7111,7161,6301,7151,702
Shares Outstanding (Diluted)
1,7111,7161,6301,7151,702
Shares Change (YoY)
-0.31%5.27%-4.92%0.70%4.96%
EPS (Basic)
0.110.070.00-0.400.01
EPS (Diluted)
0.110.070.00-0.400.01
EPS Growth
44.59%2366.67%---81.67%
Free Cash Flow
634.53445.35401.23454.81502.75
Free Cash Flow Per Share
0.370.260.250.270.29
Dividend Per Share
-0.0300.010-0.060
Dividend Growth
-200.00%--100.00%
Gross Margin
31.00%31.79%31.75%32.73%35.57%
Operating Margin
6.72%6.82%5.30%6.05%5.78%
Profit Margin
1.98%1.29%0.05%-6.56%0.18%
Free Cash Flow Margin
6.87%4.51%3.96%4.33%4.84%
EBITDA
1,5161,4611,2751,3471,224
EBITDA Margin
16.40%14.81%12.60%12.83%11.79%
D&A For EBITDA
894.34788.52739.01712624
EBIT
621.36672.93536.44634.8600.11
EBIT Margin
6.72%6.82%5.30%6.05%5.78%
Effective Tax Rate
27.97%30.62%68.85%-73.77%
Revenue as Reported
9,2429,87010,12010,50010,385
Advertising Expenses
-119.86133.01127.89185.19
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.